In October 2000, treatment of opioid dependence was transformed by Congressional approval of the Drug Addiction Treatment Act (DATA 2000).
Under DATA 2000, qualified physicians may obtain a waiver allowing them to prescribe and/or dispense approved Schedule III-V medications for the treatment of opioid dependence. Previously, this type of treatment was available only in federally approved Opioid Treatment Programs, namely, methadone clinics.
For the first time in more than 30 years, qualifying physicians have the legal right to use approved opioid medications (eg, SUBOXONE) to treat opioid dependence in the privacy of an office-based setting.
To become certified to prescribe SUBOXONE for office-based treatment of opioid dependence (ie, to receive a DATA 2000 waiver), physicians must complete 2 steps:
| 1. | Prove that they are qualified |
| 2. | Notify the Substance Abuse and Mental Health Services Administration (SAMHSA) of their intent to treat patients with SUBOXONE |
For second notifications:
SAMHSA/CSAT will formally acknowledge your submission of the second notification by letter; however, unless you are notified of the contrary, the "good faith" submission of the second notification permits treatment of up to 100 patients.